Avalo Therapeutics announced the addition of multiple biotech leaders to its Board of Directors. The Avalo Board brings together a team with expertise spanning finance, business operations, drug discovery and clinical development. The recent board appointments include Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent Directors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX:
- Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
- Avalo Reports 2023 Financial Results and Provides Business Updates
- Avalo Therapeutics’ Strategic Expansion and Leadership Revamp
- Avalo Therapeutics up 227% afterhours at $15.60 after announcing AlmataBio deal
- Avalo Therapeutics to sell 12M shares at $5.80 in private placement
